Search results for: 'mee1 api mining pace industry'

05 Apr 2023  |  Asia Pacific  |  Market Outlook

Asia-Pacific Pharmaceutical Industry Outlook, 2023

Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry

Infographics

×

Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

10 Jul 2015  |  Asia Pacific  |  Market Research

APAC Contract Research Organisation (CRO) Market

An Analysis of Trends Transforming the CRO Industry

Infographics

×

The research service presents an overview and analysis of the Asia-Pacific (APAC) contract research organisation (CRO) market and provides revenue forecasts by phase and therapeutic type. It discusses the major issues and challenges, unmet needs, and emerging trends in the market and covers the complete life cycle of the CRO industry, from pre-cli...

This study provides data for the Russian in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, immunochemistry, and others namely, tissue diagnostics and self-monitoring blood glucose, are the segments discussed in this market. Market reve...

The Singapore private outpatient diagnostic imaging services market offers insights on diagnostic imaging products such as computed tomography scanners, magnetic resonance imaging, X-ray, mammogram, positron emission tomography, and single-photon emission computed tomography used in polyclinics, private hospitals, and diagnostic centers. Procedura...

This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as we...

23 Mar 2017  |  Asia Pacific  |  Market Research

APAC Molecular Diagnostics Market, Forecast to 2021

Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

Infographics

×

The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...

Southeast Asia (SEA) is emerging as the gold mine for both local and international healthcare vendors. Within SEA, Malaysia, Singapore, and Indonesia still have unexplored and under-served markets providing boundless opportunities for healthcare vendors with innovative products and services. To be able to capitalize on the market, medical device ma...

The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores oppor...